{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Nesari T"],"pubmed_abstract":["<h4>Objective</h4>The world continues to face the COVID-19 crisis, and efforts are underway to integrate traditional medicine interventions for its effective management. The study aimed to determine the efficacy of the \"AYURAKSHA\" kit in terms of post-interventional percentage of COVID-19 IgG positivity, immunity levels, and quality of life (QoL) against COVID-19.<h4>Method</h4>This was a non-randomized controlled, prospective intervention trial, done after the distribution of 80,000 AYURAKSHA kits (constituent of Sanshamani Vati, AYUSH Kadha, and Anu Taila) among Delhi police participants in India. Among 47,827 participants, the trial group (<i>n</i> = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and th"],"journal":["Frontiers in public health"],"pagination":["920126"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9424736"],"repository":["biostudies-literature"],"pubmed_title":["AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial."],"pmcid":["PMC9424736"],"pubmed_authors":["Mandal SK","Ruknuddin G","Ghildiyal S","Bhatted SK","Kundal P","Kajaria D","Venkatramana Sharma AP","Vyas M","Mahto RR","Sherkhane R","Prajapati PK","Deogade M","Mahapatra AK","Kapoor A","Rai S","Bavalatti N","More A","Kadam S","Harti SK","Yadav PR","Nesari T","Tripathi R","Pathak P","Bhide B","Rajagopala SK","Huddar VG","Dharmarajan P","Tagade U","Bhojani M","Saini H","Rajagopala M","Mahanta V","Kumar A","Yadav RK","Sandrepogu J"],"additional_accession":[]},"is_claimable":false,"name":"AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.","description":"<h4>Objective</h4>The world continues to face the COVID-19 crisis, and efforts are underway to integrate traditional medicine interventions for its effective management. The study aimed to determine the efficacy of the \"AYURAKSHA\" kit in terms of post-interventional percentage of COVID-19 IgG positivity, immunity levels, and quality of life (QoL) against COVID-19.<h4>Method</h4>This was a non-randomized controlled, prospective intervention trial, done after the distribution of 80,000 AYURAKSHA kits (constituent of Sanshamani Vati, AYUSH Kadha, and Anu Taila) among Delhi police participants in India. Among 47,827 participants, the trial group (<i>n</i> = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and th","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-22T07:01:46.793Z","creation":"2025-04-05T21:57:46.816Z"},"accession":"S-EPMC9424736","cross_references":{"pubmed":["36052011"],"doi":["10.3389/fpubh.2022.920126"]}}